CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY
Trials shown by sponsor
| Public title |
Date of Registration |
State |
|---|---|---|
| Efficacy and safety of Jusvinza treatment in patients with acute respiratory distress syndrome. Phase II/III | 24/04/2023 | Registered |
| ESAR-814 Study | 26/01/2017 | Registered |
| VISION Study | 26/10/2021 | Registered |
| ABDALA Clinical Study | 26/11/2020 | Registered outdated |
| MAMBISA Study | 26/11/2020 | Registered outdated |
| ABDALA-Intervention | 27/03/2021 | Registered |
| COURAGE Study | 27/05/2016 | Registered |
| Growth hormone-releasing peptide in sepsis-induced myocardial dysfunction. | 28/03/2026 | Registered |
| ATENEA-Co-300 study | 28/05/2020 | Registered outdated |
| Nasalferon in ARI | 29/07/2022 | Registered |
| Retrospective observational study of the administration of Jusvinza, for the management of COVID-19 at the Hospital “Dr. Luis Diaz Soto”. | 29/10/2021 | Registered |
| CENTAURO-4 Study | 30/04/2017 | Registered outdated |
| HEBERBIOVAC HB vaccine to reference material. | 30/04/2017 | Registered |
| Effectiveness and Safety of Jusvinza in Patients with Chikungunya | 31/03/2026 | Registered |